SG 155 Pill — YELLOW OVAL, 10mm — Atorvastatin

No photo available

Imprint	SG / 155
Colour	YELLOW
Shape	OVAL
Size	10
Strength	ATORVASTATIN CALCIUM 80 mg
Dosage form	Tablet, Film Coated
Manufacturer	Aphena Pharma Solutions - Tennessee, LLC
NDC	71610-094
Schedule	—
Availability	—
Ingredients	ATORVASTATIN CALCIUM[ATORVASTATIN]

What does this imprint mean?

The imprint "SG 155" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Atorvastatin

Uses and warnings

Key warnings include: - Myopathy/Rhabdomyolysis: Risk factors include age ≥65 years, uncontrolled hypothyroidism, renal impairment, concomitant drugs, and higher doses. "Discontinue atorvastatin calcium if markedly elevated CK levels occur or myopathy is diagnosed or suspected." - Immune-Mediated Necrotizing Myopathy (IMNM): Rare autoimmune myopathy reported with statins; discontinue if suspected. - Hepatic Dysfunction: Transaminase increases reported; contraindicated in acute liver failure or decompensated cirrhosis. "If serious hepatic injury with clinical symptoms...occurs, promptly discontinue." - HbA1c/Glucose: Increases in blood sugar levels reported. - Hemorrhagic Stroke Risk: Increased hemorrhagic stroke incidence at 80 mg dose in patients with recent hemorrhagic stroke.

Atorvastatin calcium tablets are indicated to: - Reduce risk of MI, stroke, revascularization procedures, and angina in adults with multiple CHD risk factors but without clinically evident CHD - Reduce risk of MI and stroke in adults with type 2 diabetes with CHD risk factors - Reduce risk of non-fatal MI, fatal/non-fatal stroke, revascularization, heart failure hospitalization, and angina in adults with clinically evident CHD - As adjunct to diet to reduce LDL-C in adults and pediatric patients (age 10+) with primary hyperlipidemia and familial hypercholesterolemia - Treat adults with primary dysbetalipoproteinemia and hypertriglyceridemia

Read the full drug profile →